decisionhealth Newsletters, Part B News - 2008 Issue 9 (September)
CMS: Bill for wasted ESA drugs
Subscribe or sign in to view the full article.
Article Overview
This CMS update discusses a Medicare Claims Processing Manual transmittal that affects billing for discarded erythropoietin stimulating agents in a narrow home dialysis context. The article is relevant to coding, billing, and reimbursement staff who need to track policy effective dates, claim-line reporting, and related Medicare guidance.
Why This Topic Matters
Understanding this CMS change helps practices and dialysis-related billing teams recognize when discarded drug amounts may be reported on claims and how the policy timing affects submission. It is important for avoiding claim errors and aligning billing workflow with Medicare instructions.
What You Will Learn
- The scope of a CMS update affecting billing for discarded drug amounts
- The Medicare context and patient setting addressed by the policy
- The documentation and claim-reporting topics discussed in the transmittal
- The effective date associated with the billing guidance
Who Should Read This
- Medical coders
- Medical billers
- Revenue cycle staff
- Dialysis billing staff
- Compliance teams
Modifiers Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com